🌍 Cardiovascular science for a changing world. The JACC Journals reaffirm our mission: advancing global health with science, integrity, and humanity—because our values matter now more than ever. 🔗 Read more: jacc.org/doi/10.1016/j.… #CardioTwitter American College of Cardiology

On March 3, 2025, doctors saved THREE lives with ONE heart. When 11-year-old Journi Kelly received a full heart transplant, her two healthy valves from her own heart were used to give two other girls a second chance at life. Here is the story behind this incredible surgery:

Our new JAMA Health Forum study adds more evidence on how MA plans enrolling veterans maximize profits by not paying for care. Veterans in high-veteran MA plans are much more likely to have surgical care paid by VA than plan itself—even when surgery occurs in non-VA hospitals…

Our new study in JACC Journals led by Brandon Yan, MD MPH highlights that hypertension (as a primary cause of death) age-adjusted death rate doubled from 15.8 per 100,000 in 1999 to 31.9 in 2023. Striking given that overall cardiovascular mortality and basically all other sub-causes have

🚨Two new JACC Advances papers drop today linking SGLT2 inhibitors ↔ apolipoprotein M (ApoM) across very different settings—ambulatory HFrEF (DEFINE-HF) and acute inflammation (LPS-sepsis & COVID-19). Let’s unpack why this kidney-liver-vascular axis matters. A 🧵 1️⃣/15

Thanks to KTVU for covering our study on heart disease deaths in JACC Journals Takeaway #1: Let's address #highbloodpressure with the urgency and concerted effort that we showed towards combatting #smoking. Takeaway #2: #Diet is a major cause - but one that we can change!

New JACC Journals Editor’s Page: A Disquieting Plateau 🫀 Cardiovascular mortality progress has stalled 📉 In some areas, it’s reversing 💡 We must confront what’s happening on our watch—and what comes next 👉 authors.elsevier.com/a/1lfjn2d9GI2A… #CardioTwitter #HealthEquity JACC Journals

The timing of the observed plateau in cardiovascular disease age-adjusted mortality rate since 2011 is perplexing (taken from Fig. 1A Brandon Yan, MD MPH et al 2025 JACC). As Harlan Krumholz writes, "our toolbox has grown: we now have more effective medications, robust trials, and clearer

Evolocumab in Patients without a Previous Myocardial Infarction or Stroke: NEJM AHA Science #AHA25 🥸VESALIUS-CV - subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab 😱Summary 👇👇👇

Get this: Coffee suppressed atrial fibrillation! Unexpected results for recurrence from a randomized trial in participants after cardioversion from AF #AHA25 JAMA ☕️ jamanetwork.com/journals/jama/…

What if saving a pneumonia patient was as simple as adding one cheap pill? A new NEJM RCT from Kenya just showed exactly that. 👇 2,180 adults with community-acquired pneumonia were randomized within 48 hrs to: 🅰️ Standard Care (WHO regimen) β-lactam

Gemini 3.0 Pro - CORRECT diagnosis and treatment Grok 4.1 - WRONG diagnosis and treatment GPT 5.2 Instant - WRONG diagnosis, partially correct Tx GPT 5.2 Thinking - WRONG GPT 5.2 Pro - CORRECT dx and tx Claude Opus 4.5 - CORRECT dx and Tx OpenEvidence - WRONG (entire

Our new JACC Journals Cardiovascular Statistics annual report provides a clear-eyed understanding of cardiovascular health in the United States. Where we stand. Where we've made gains. And where we're falling behind. #JACCStats jacc.org/doi/10.1016/j.…

JACC Stats 2026 is out. A clear look at U.S. cardiovascular health shows stalled progress, rising burden, and persistent gaps across hypertension, diabetes, obesity, heart failure, and more. We cannot improve what we do not measure. JACC Journals jacc.org/doi/10.1016/j.…